These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 2208158)

  • 1. Immunotherapy of tumor-bearing mice utilizing virus help.
    Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
    Cancer Immunol Immunother; 1988; 27(3):223-7. PubMed ID: 3263207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.
    Okada H; Wakamiya N; Okada N; Kato S
    Cancer Immunol Immunother; 1987; 25(1):7-9. PubMed ID: 3594492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of oncolytic viruses in the treatment of multiple myeloma.
    Bartee E
    Oncolytic Virother; 2017; 7():1-12. PubMed ID: 29503813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
    Patel PM; Flemming CL; Russell SJ; McKay IA; MacLennan KA; Box GM; Eccles SA; Collins MK
    Br J Cancer; 1993 Aug; 68(2):295-302. PubMed ID: 8347485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells.
    Gopas J; Itzhaky D; Segev Y; Salzberg S; Trink B; Isakov N; Rager-Zisman B
    Cancer Immunol Immunother; 1992; 34(5):313-20. PubMed ID: 1347254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possible connection of the vaccinia virus and carcinogenesis].
    Merekalova ZI; Mazurenko NP; Voronov AV; Mazurenko NN; Iakovleva LS
    Vopr Virusol; 1987; 32(3):323-7. PubMed ID: 3314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor efficacy of two kinds of tumor vaccine modified with vaccinia virus.
    Ito T; Okabayashi M; Osada Y; Wakamiya N; Kato S
    In Vivo; 1988; 2(5):325-9. PubMed ID: 2979853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional evidence for the augmented induction of tumor-specific resistance in vaccinia virus-primed mice by immunization with vaccinia virus-modulated syngeneic tumor cells.
    Ueda S; Wakamiya N; Wu KS; Kato S; Fujiwara H; Hamaoka T
    Biken J; 1984 Mar; 27(1):1-7. PubMed ID: 6385960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of syngeneic tumor growth in vaccinia virus-primed mice by immunization with vaccinia virus-modulated tumor cells.
    Wu KS; Ueda S; Sakaue Y; Ohashi Y; Ikuta K; Sugano T; Kato S
    Biken J; 1981 Dec; 24(4):153-8. PubMed ID: 7346041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity.
    Wakamiya N; Wang YL; Imai H; Gu HX; Ueda S; Kato S
    Cancer Immunol Immunother; 1986; 23(2):125-9. PubMed ID: 3779714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy of vaccinia virus-modified tumor cell vaccine.
    Ito T; Wang DQ; Maru M; Nakajima K; Kato S; Kurimura T; Wakamiya N
    Cancer Res; 1990 Nov; 50(21):6915-8. PubMed ID: 2208158
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.